Prognostic relevance of myelodysplasia in de novo and secondary AML.

被引：0
|
作者：
Schaekel, U [1 ]
Brocard, B [1 ]
Kroschinsky, F [1 ]
Schaich, M [1 ]
Soucek, S [1 ]
Neubauer, A [1 ]
Ehninger, G [1 ]
机构：
[1] Tech Univ Dresden, Univ Klinikum CG Carus, Med Klin & Poliklin 1, Study Ctr AML96,Study Grp, D-8027 Dresden, Germany
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
453
引用
收藏
页码：106A / 106A
页数：1
相关论文
共 50 条
  • [1] FLOW CYTOMETRY IMMUNOPHENOTYPING IN CEBPA-DM DE NOVO AML. BIOLOGIC AND PROGNOSTIC RELEVANCE
    Fernandez, M.
    Pratcorona, M.
    Garrido, A.
    Estivill, C.
    Esteve, J.
    Salamero, O.
    Tormo, M.
    Arnan, M.
    Bellosillo, B.
    Zamora, L.
    Vives, S.
    Guardia, R.
    Brunet, S.
    Sierra, J.
    Nomdedeu, J.
    HAEMATOLOGICA, 2017, 102 : 673 - 673
  • [2] CEBPA Methylation as a Prognostic Biomarker in Adult Patients with De Novo AML.
    Chen, Hsin-Yu
    Lin, Tsung-Chin
    Chou, Wen-Chien
    Hou, Hsin-An
    Tien, Hwei-Fang
    Lin, Liang-In
    BLOOD, 2009, 114 (22) : 628 - 628
  • [3] Unrelated donor marrow transplantation for acute myelogenous leukemia (AML), myelodysplasia, and secondary AML.
    Drobyski, WR
    Horowitz, M
    Pietryga, D
    Margolis, D
    Juckett, M
    Burns, W
    Camitta, B
    Rowlings, P
    KeeverTaylor, C
    Casper, J
    BLOOD, 1996, 88 (10) : 1063 - 1063
  • [4] Comparison of functional differences in haemopoietic growth factor receptors in de novo and secondary AML.
    Smith, MA
    Pallister, CJ
    Singer, CRJ
    Smith, JG
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 32 - 32
  • [5] Minimal residual disease in adults with de novo AML.
    Wormann, B
    Konemann, S
    Grove, D
    Toepker, S
    Sauerland, AHB
    Buchner, T
    Hiddemann, W
    Terstappen, LWMM
    BLOOD, 1995, 86 (10) : 1313 - 1313
  • [6] Cell cycle arrest and therapeutic sensitivity in de novo AML.
    Banker, D
    Willman, C
    Groudine, M
    Appelbaum, F
    BLOOD, 1997, 90 (10) : 290 - 290
  • [7] Prognostic significance of trilineage myelodysplasia and its association with karyotype in de novo acute myeloid leukemia (AML).
    Baranova, OY
    Volkova, MA
    Frenkel, MA
    Fleishman, EV
    BLOOD, 2003, 102 (11) : 225B - 226B
  • [8] Reasons for treating secondary AML as de novo AML
    Ostgard, Lene Sofie Granfeldt
    Kjeldsen, Eigil
    Holm, Mette Skov
    Brown, Peter De Nully
    Pedersen, Bjarne Bach
    Bendix, Knud
    Johansen, Preben
    Kristensen, Jorgen Scholer
    Norgaard, Jan Maxwell
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (03) : 217 - 226
  • [9] Prognostic relevance of pretherapeutic in-vitro chemosensitivity testing in adult AML.
    Staib, P
    Lathan, B
    Michel, K
    Janz, E
    Schinkothe, T
    Diehl, V
    BLOOD, 1996, 88 (10) : 1447 - 1447
  • [10] Prognostic factors in adult patients with de novo AML. Preliminary results of the GOELAM2 trial.
    Harousseau, JL
    Witz, B
    Lioure, B
    Lamy, T
    Solary, E
    Ifrah, N
    Guyotat, D
    Abgrall, JF
    Cahn, JY
    BLOOD, 2000, 96 (11) : 324A - 324A
12345